Headlines

Prevent type 2 diabetes blood-sugar spikes by eating more protein for breakfast, experts say

Individuals with Type 2 Diabetes have difficulty regulating their glucose — or blood sugar — levels, particularly after meals. Now, University of Missouri researchers have found that Type 2 diabetics can eat more protein at breakfast to help reduce glucose spikes at both breakfast and lunch.

DiabetesHealth – Drug And Food Interactions: More Common Than You Think

Food and drug interactions are much more common than most people realize. Many people on prescription drugs probably already know it’s a bad idea to drink alcohol, which can interfere with many medications. But foods as seemingly innocuous as sausage and cheddar cheese can cause dangerous side effects for those taking certain types of antidepressants.

NPR – PepsiCo Swaps Diet Drink’s Aspartame For Other Artificial Sweeteners

If you like the idea of zero or low-calorie sodas, but you’re turned off by the artificial sweetener aspartame, you’re not alone. Sales of diet soda have fallen off significantly in the U.S. And when PepsiCo started asking consumers what they didn’t like, aspartame was at the top of the list.

Engadget – Diabetes app One Drop shares your blood sugar levels with strangers

Living with diabetes means tracking your meals and insulin level. The new One Drop app for iOS (an Android version is planned) aims to not only make that monitoring easier, but also use the logged information to help the larger diabetic community.

WebMD – Study Tests Powdered Insulin to Prevent Diabetes

Swallowing a daily dose of insulin is safe, and it may act like a vaccine to prevent type 1 diabetes, a small new study shows. If the results can be repeated in larger and longer trials, the approach may one day be used to help young children at high risk of the disease avoid getting […]

DiabetesMine – Amazing Afrezza: Non-Invasive Insulin That Works! (Complete Review)

I can’t wait to get my next A1C test done (who says that?! but it’s true). I am now two-plus months into my use of new inhaled insulin Afrezza, and frankly I’m blown away by how well it performs.

Google Secures Patent for Glucose-Sensing Contact Lens

Google recently received a patent for its glucose-sensing contact lens, providing the first major update we’ve heard on this project since last July. The patent does not necessarily reflect Google’s latest or final design of the glucose-sensing lens, but it does indicate continued work and interest in the project.

Why The FDA Action Against KIND Bars Doesn’t Mean They’re Unhealthy

KIND Snacks, the company behind fruit, nut and grain bars (tag line: “ingredients you can see & pronounce”) have been asked by the Food and Drug Administration to strip any mention of the term “healthy” from its packaging and website, as well as the “+” symbol.

Study shows that use of statins increases risk of developing diabetes by 46%

New research published in Diabetologia (the journal of the European Association for the Study of Diabetes) shows that use of statins is associated with a 46% increase in the risk of developing diabetes, even after adjustment for confounding factors.

HuffPost – 10 Foods That Fight Inflammation

Chronic inflammation is a common thread among a wide spread of conditions like stroke, cancer, obesity, Alzheimer’s, heart disease, arthritis and depression, according to Men’s Journal.

Type2Nation – 6 Ways to Run Safely with Diabetes

Running is one of the easiest forms of fitness, but that doesn’t mean you’re doing it right. Poor technique, misinformation and bad preparation are common, and can lead to long-term injury, especially in people with Type 2 Diabetes.

3 More Diabetes Anti-Discrimination Laws

In our recent series on what the law says about diabetes workplace discrimination we’ve been focusing on the protections offered by the Americans with Disabilities Act. However, there are several other laws which also cover workplace discrimination and diabetes, especially when it comes to complications with the condition.

DiabetesMine – New ‘Insulin Angel’ Aims to Look After Your Diabetes Meds

Ever have an issue forgetting your insulin at home, at school or in the office? Or do you worry that freezing or sweltering weather might kill your insulin?

DiabetesMine – Who Says Big Pharma Isn’t Investing in Finding a Diabetes Cure?

Just the other day, we had a good April 1 laugh about all the hyped-up diabetes “cure” headlines. But today, we’re looking more seriously at how Big Pharma is putting its money where its mouth is, as in fighting diabetes for real by investing in cure research. No joke.

DiabetesInControl – MiniMed 640G Insulin Pump System Mimics Healthy Pancreas

The new device, available in Australia, Denmark, and the U.K., is small, about the size of a MP3 player. The system is the first in the world to both automatically suspend insulin delivery when sensor glucose levels are predicted to approach a low limit and resume insulin delivery once sensor glucose levels recover.

Can a Tuberculosis Vaccine Combat Type 1?

Sometimes, promising Type 1 diabetes treatments are developed from treatments for other conditions. If you have Type 1 diabetes, there’s good reason to be interested in what’s happening with the BCG vaccine, a treatment used to curb the spread of tuberculosis.

Toujeo Launches in the US – The Next Generation Lantus

New basal insulin Toujeo (insulin glargine U300) has now launched in the US, around a month after its FDA approval. In what we think is fantastic news, Toujeo will be priced around the same as Lantus (insulin glargine U100) per unit.

One Pill, One Co-pay: Combo Drug Glyxambi Now Available in the US

On March 23, Lilly/BI announced the US launch of Glyxambi at pharmacies nationwide. This comes two months after FDA approval and represents the first SGLT-2 inhibitor/DPP-4 inhibitor fixed dose combination drug available in the US. Its main benefit is combining two different diabetes drugs into a single pill (in this case, Tradjenta and Jardiance) with […]

Test Driving New Inhaled Insulin Afrezza

I have been using Afrezza, the new inhaled insulin developed by MannKind and marketed by Sanofi, for the last three and a half weeks. So far it’s… mysterious and exciting. Mysterious because the dosing seems ridiculously imprecise compared to the micro-unit counts I’m used to with an insulin pump.

CNN – Vegetarians who eat fish could be greatly reducing their risk of colon cancer

Dropping red meat, and sticking to a plant-based diet that incorporates fish may be the key to preventing colorectal (colon and rectum) cancers, according to a seven-year study published Monday. Pescetarians, as they are commonly referred, had a 43% lower chance of getting the cancer compared to people with omnivorous diets.



Other News

ACLS Class

  • Get ACLS and PALS certified online with ACLSclass.com’s fast programs.
  • Health Partner